Results 141 to 150 of about 8,213 (210)

Bortezomib-Induced Sensorineural Hearing Loss May Be Reversible with Intratympanic Dexamethasone. [PDF]

Hematol Rep
Peláez Casillas N, Verdaguer Muñoz JM, Rodríguez Valiente A, Romera Martínez I, García Berrocal JR.   +4 more
europepmc   +1 more source

Pharmacologic Inhibition of JAK1/2 Potentiates Aminoglycoside-Induced Ototoxicity. [PDF]

Otol Neurotol
Fleegel J, Ezzat I, Vijayakumar S, Zallocchi M, Zuo J.   +4 more
europepmc   +1 more source

Laser ablation-inductively coupled plasma-mass spectrometry 2D elemental bioimaging of cisplatin-induced nephrotoxic side effects [PDF]

, 2016
Cuyckens, Filip, Van Acker, Thibaut, Van Heerden, Marjolein, Van Malderen, Stijn, Vanhaecke, Frank   +4 more
core   +1 more source

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial. [PDF]

IJTLD Open
Snobre J, Gasana J, Decroo T, Mucyo Y, Jacobs BKM, Rigouts L, Martin IC, Herssens N, Hakizayezu F, Ntihumbya JB, Kilibazayire A, de Viron E, Runyambo D, Ndayishimiye C, Merle CS, Muvunyi CM, Migambi P, Sturkenboom MGG, de Jong BC, Ngabonziza JCS.   +19 more
europepmc   +1 more source

Improving the usability of grading scales for drug-induced ototoxicity with a focus on real world data collection. [PDF]

Eur Arch Otorhinolaryngol
Koot M, Crul M, van Balen D, Schutte T.
europepmc   +1 more source

Approaches to managing ototoxicity in the workplace. [PDF]

Int J Audiol
Morata TC, Carlson K, Fuente A, Poling GL, Garinis A, Hullar T, Lee J, Pouyatos B, Sliwinska-Kowalska M, Dreisbach L, Stuehm H, Konrad-Martin D.   +11 more
europepmc   +1 more source

Monitoring Ototoxicity with DPOAEs

, 2016
openaire   +1 more source

Unraveling Endocannabinoid Signaling Pathways in Cisplatin-Induced Ototoxicity. [PDF]

FASEB J
Palaniappan S, Tisi A, Di Meo C, Urbano C, Fenton GE, Della Valle F, Fanti F, Compagnone D, Nazarè M, Versnel H, Aramini A, Allegretti M, Maccarrone M.   +12 more
europepmc   +1 more source

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB. [PDF]

IJTLD Open
Souleymane MB, Decroo T, Soumana A, Lawan IM, Aboubacar AC, Gagara-Issoufou A, Moussa RH, Kabirou AA, Hamidou I, Moussa SH, Adamou M, Adehossi E, Mamadou S, de Jong BC, Rigouts L, Piubello A.   +15 more
europepmc   +1 more source

Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review. [PDF]

Antioxidants (Basel)
Zadrożniak M, Biskupski M, Szymański M, Łuszczki JJ.   +3 more
europepmc   +1 more source